diabetes

GLP-1 medications show mixed effects on body contouring outcomes

by

For patients undergoing body contouring surgery to remove excess abdominal skin after massive weight loss, use of GLP-1 weight-loss medications may have mixed effects on complication risks, suggests a study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer. “As GLP-1 receptor agonist [GLP1ra] medications become increasingly integrated into the care … Read more

New algorithm enables precise subtyping of metabolic liver disease

by

Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% individuals globally. The disease is conventionally staged by histological progression, ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) and ultimately fibrosis or cirrhosis. Beyond liver-related outcomes, MASLD significantly elevates the risk of extrahepatic complications, including cardiovascular … Read more

Replacing sedentary time improves insulin resistance in adolescents

by

Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart … Read more

Losing health insurance worsens diabetes outcomes in low-income adults

by

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University, The study, published today in JAMA Health Forum, found that low-income adults with diabetes who experienced insurance “churn” – defined as losing coverage … Read more

A 60-Year-Old Diabetes Drug Just Revealed Astonishing Effects on the Brain

by

A venerable diabetes drug has returned to the spotlight, not for its blood-sugar benefits alone, but for a surprising effect on the brain. After more than sixty years of routine use, researchers now point to a neural mechanism that may help explain metformin’s wide-ranging impact. The finding connects metabolism to brain circuits in a way … Read more

Galway voices to feature at Thriveabetes 2026

by

Thriveabetes 2026, Ireland’s only volunteer-led national Type 1 Diabetes conference, is organised by volunteers from across the country. Galway has a significant presence at this year’s Thriveabetes conference, with both speakers and volunteers contributing lived experience, advocacy and professional expertise. The event takes place on Saturday, 18 April 2026 at the Crowne Plaza Dublin Airport, … Read more

AI diet plans underestimate teen nutrition and miss key nutrients

by

New research reveals that popular AI tools may be giving adolescents incomplete and imbalanced diet advice, raising important questions about whether these technologies are ready to guide growing bodies without expert oversight.  Study: Artificial intelligence diet plans underestimate nutrient intake compared to dietitians in adolescents. Image credit: ilona.shorokhova/Shutterstock.com Artificial intelligence (AI) is increasingly used for … Read more

Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds

by

Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental disorders, according to a new study. ADVERTISEMENT ADVERTISEMENT The research, published in The Lancet Psychiatry, found that people following a GLP-1 treatment for diabetes and obesity had a lower need for hospital care and medical leave due to psychiatric … Read more

Tailored prediabetes treatment may better prevent Type 2 diabetes

by

A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing Type 2 diabetes, according to preliminary research presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17-20, 2026, and offers the latest science … Read more

Patients who stop GLP-1 drugs often restart or try alternatives

by

A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or try alternative therapies, helping explain why average weight regain after discontinuation may be smaller than expected. Study: Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide. Image credit: KaterynaBorodina/Shutterstock.com Obesity treatment has … Read more